Syndromic parkinsonism and dementia associated with OPA1 missense mutations.

TitleSyndromic parkinsonism and dementia associated with OPA1 missense mutations.
Publication TypeJournal Article
Year of Publication2015
AuthorsCarelli, V, Musumeci, O, Caporali, L, Zanna, C, La Morgia, C, Del Dotto, V, Porcelli, AMaria, Rugolo, M, Valentino, MLucia, Iommarini, L, Maresca, A, Barboni, P, Carbonelli, M, Trombetta, C, Valente, EMaria, Patergnani, S, Giorgi, C, Pinton, P, Rizzo, G, Tonon, C, Lodi, R, Avoni, P, Liguori, R, Baruzzi, A, Toscano, A, Zeviani, M
JournalAnn Neurol
Date Published2015 Jul
KeywordsAged, Dementia, Female, Genetic Predisposition to Disease, GTP Phosphohydrolases, Humans, Italy, Male, Mutation, Missense, Ophthalmoplegia, Chronic Progressive External, Parkinsonian Disorders, Pedigree

OBJECTIVE: Mounting evidence links neurodegenerative disorders such as Parkinson disease and Alzheimer disease with mitochondrial dysfunction, and recent emphasis has focused on mitochondrial dynamics and quality control. Mitochondrial dynamics and mtDNA maintenance is another link recently emerged, implicating mutations in the mitochondrial fusion genes OPA1 and MFN2 in the pathogenesis of multisystem syndromes characterized by neurodegeneration and accumulation of mtDNA multiple deletions in postmitotic tissues. Here, we report 2 Italian families affected by dominant chronic progressive external ophthalmoplegia (CPEO) complicated by parkinsonism and dementia.

METHODS: Patients were extensively studied by optical coherence tomography (OCT) to assess retinal nerve fibers, and underwent muscle and brain magnetic resonance spectroscopy (MRS), and muscle biopsy and fibroblasts were analyzed. Candidate genes were sequenced, and mtDNA was analyzed for rearrangements.

RESULTS: Affected individuals displayed a slowly progressive syndrome characterized by CPEO, mitochondrial myopathy, sensorineural deafness, peripheral neuropathy, parkinsonism, and/or cognitive impairment, in most cases without visual complains, but with subclinical loss of retinal nerve fibers at OCT. Muscle biopsies showed cytochrome c oxidase-negative fibers and mtDNA multiple deletions, and MRS displayed defective oxidative metabolism in muscle and brain. We found 2 heterozygous OPA1 missense mutations affecting highly conserved amino acid positions (p.G488R, p.A495V) in the guanosine triphosphatase domain, each segregating with affected individuals. Fibroblast studies showed a reduced amount of OPA1 protein with normal mRNA expression, fragmented mitochondria, impaired bioenergetics, increased autophagy and mitophagy.

INTERPRETATION: The association of CPEO and parkinsonism/dementia with subclinical optic neuropathy widens the phenotypic spectrum of OPA1 mutations, highlighting the association of defective mitochondrial dynamics, mtDNA multiple deletions, and altered mitophagy with parkinsonism.

Alternate JournalAnn. Neurol.
Citation Key10.1002/ana.24410
PubMed ID25820230